Curis Lifesciences IPO Listing at 14.14% premium at ₹146 Per Share

Click and Sign Up to Get Latest Updates on Curis Lifesciences Limited

Curis Lifesciences IPO Listing:

On the NSE SME platform, shares are listed at ₹146 per share, reflecting a premium of 14.14% against the issue price of 128 per share. 

Curis Lifesciences IPO Subscription Status

The Curis Lifesciences IPO was subscribed 74.39 times at the close of the bidding. In this subscription, qualified institutional buyers (QIBs) received 96.17 times the allocation, and non-institutional investors (NIIs) received 115.46 times the allocation. The retail quota of the issue was subscribed to 33.30%. 

Curis Lifesciences IPO: Check Key Details

The issue is entirely a fresh issue of 22,00,000 shares. The IPO is expected to be listed on the NSE and SME with a tentative listing date of 14th November 2025. The Curis Lifesciences IPO is expected to take place from 7th November 2025 to 11th November 2025. The face value of Curis Lifesciences IPO shares is ₹2 per share, and the IPO price is set at ₹120 to ₹128 per share.

About Curis Lifesciences Limited

Curis Lifesciences Limited was established in 2010 and is a prominent pharmaceutical company that engages in the development, manufacturing, and distribution of various products. It has manufacturing units globally and domestically, through licenses and on a contract basis, and it has its own brand marketing. 

• Experienced Promoters and Management Team
• Wide range of Products
• Strategic Location of Manufacturing Facility
• Scalable Business Model
• Quality assurance

Curis Lifesciences Limited Financials

The company’s financial analysis is essential before applying for Curis Lifesciences Limited’s IPO. Look at the table to learn about Curis Lifesciences Limited’s financials. 

Explanation

Curis Lifesciences Limited’s revenue increased by 38% from ₹4.87 crores in March 2024 to ₹49.65 crores in March 2025. Moreover, the company’s PAT increased by 25% from ₹4.87 crores to ₹6.11  crores. Investors can analyse other relevant factors and make a decision accordingly.

Objectives of the Curis Lifesciences IPO

The primary objective of the Curis Lifesciences IPO is to raise ₹27.52 crore. However, before applying for the IPO, you should be aware of its secondary objectives. Explore them below

• Capital Expenditure towards Upgradation/Improvement of the existing Manufacturing Facilities.
• Capital Expenditure towards Construction of a Storage Facility
• Pre-payment/Repayment of outstanding Secured Loans
• Product Registrations in other countries
• Funding our Working Capital Requirements
• General Corporate Purposes

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!

Recent Articles

Nestle Q2 Results FY26: Q2 PAT Falls 17.38% to ₹743.17 Crore; Revenue Up 10.57% YoY

Inspira Enterprise India IPO Details: Everything You Should Know about 

Swaraj Engines Q2 Results FY26: Q2 PAT Rises 8.88% to ₹49 Crore; Revenue Up 8.62% YoY

HDB Financial  Q2 Results FY26: Q2 PAT Falls 1.5% to ₹581 Crore; Revenue Up 13.42% YoY

BEL Gears Up for Q2 Reveal on 4th November; Check Key Expectations Here

Paytm Gears Up for Q2 Reveal on 4th November; Check Key Expectations Here

Blue Dart Gears Up for Q2 Reveal on 28th October; Check Key Expectations Here